LOS ANGELES CAPITAL MANAGEMENT LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 118 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$1,401,000
-16.9%
26,520
-3.5%
0.01%
-25.0%
Q2 2020$1,685,000
+136.7%
27,495
+118.6%
0.01%
+60.0%
Q1 2020$712,000
+148.1%
12,579
+165.7%
0.01%
+150.0%
Q4 2018$287,000
+1.1%
4,734
-2.6%
0.00%
+100.0%
Q3 2018$284,000
+30.3%
4,8590.0%0.00%0.0%
Q2 2018$218,000
+1.4%
4,8590.0%0.00%0.0%
Q1 2018$215,000
+1.9%
4,8590.0%0.00%0.0%
Q4 2017$211,000
-5.4%
4,859
+1.6%
0.00%0.0%
Q3 2017$223,0004,7840.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q1 2019
NameSharesValueWeighting ↓
JW Asset Management, LLC 73,649$3,646,0002.32%
Stonepine Capital Management, LLC 59,878$2,965,0001.60%
NORTHPOINTE CAPITAL LLC 109,644$5,428,0000.57%
Elk Creek Partners, LLC 145,406$7,199,0000.47%
TFS CAPITAL LLC 18,208$901,0000.35%
RICE HALL JAMES & ASSOCIATES, LLC 161,671$8,004,0000.35%
Ativo Capital Management LLC 19,592$970,0000.26%
Matarin Capital Management, LLC 57,034$2,823,753,0000.26%
ISTHMUS PARTNERS, LLC 16,505$817,0000.24%
Stanley-Laman Group, Ltd. 12,546$621,0000.17%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders